{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:53:02Z","timestamp":1765295582538,"version":"3.46.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1245\/s10434-025-18357-8","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T15:30:12Z","timestamp":1758727812000},"page":"255-264","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Survival Benefit of Adjuvant S-1 Chemotherapy in Patients Aged \u2265 80 Years with Gastric Cancer after Curative Resection: A Multicenter Cohort Study"],"prefix":"10.1245","volume":"33","author":[{"given":"Shutaro","family":"Sumiyoshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Takabatake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Nishibeppu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiya","family":"Ochiai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Ariyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Toma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuki","family":"Yamaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soujin","family":"Sai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shozo","family":"Ide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Hatakeyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Itokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiaki","family":"Ochi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miho","family":"Sekimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Shikata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Shiozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,24]]},"reference":[{"key":"18357_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin."},{"key":"18357_CR2","doi-asserted-by":"publisher","first-page":"6695","DOI":"10.7150\/jca.62734","volume":"12","author":"T Zhang","year":"2021","unstructured":"Zhang T, Chen H, Zhang Y, et al. Global changing trends in incidence and mortality of gastric cancer by age and sex, 1990\u20132019: findings from Global Burden of Disease Study. J Cancer. 2021;12:6695\u2013705.","journal-title":"J Cancer."},{"key":"18357_CR3","doi-asserted-by":"crossref","unstructured":"Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer. 2021; 24: 1-21.","DOI":"10.1007\/s10120-020-01042-y"},{"key":"18357_CR4","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1056\/NEJMoa072252","volume":"357","author":"S Sakuramoto","year":"2007","unstructured":"Sakuramoto S, Sasako M, Yamaguchi T, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357:1810\u201320.","journal-title":"N Engl J Med."},{"key":"18357_CR5","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0140-6736(11)61873-4","volume":"379","author":"YJ Bang","year":"2012","unstructured":"Bang YJ, Kim YW, Yang HK, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (Classic): a phase 3 open-label, randomised controlled trial. Lancet. 2012;379:315\u201321.","journal-title":"Lancet."},{"key":"18357_CR6","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1200\/JCO.18.01138","volume":"37","author":"K Yoshida","year":"2019","unstructured":"Yoshida K, Kodera Y, Kochi M, et al. Addition of docetaxel to oral fluoropyrimidine improves efficacy in patients with Stage III gastric cancer: interim analysis of JACCRO GC-07, a randomized controlled trial. J Clin Oncol. 2019;37:1296\u2013304.","journal-title":"J Clin Oncol."},{"key":"18357_CR7","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.annonc.2020.11.017","volume":"32","author":"SH Park","year":"2021","unstructured":"Park SH, Lim DH, Sohn TS, et al. A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: The ARTIST 2 trial\u2606. Ann Oncol. 2021;32:368\u201374.","journal-title":"Ann Oncol."},{"key":"18357_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2020.101980","volume":"85","author":"N Joharatnam-Hogan","year":"2020","unstructured":"Joharatnam-Hogan N, Shiu KK, Khan K. Challenges in the treatment of gastric cancer in the older patient. Cancer Treat Rev. 2020;85:101980.","journal-title":"Cancer Treat Rev."},{"key":"18357_CR9","doi-asserted-by":"publisher","first-page":"88","DOI":"10.7150\/jca.13248","volume":"7","author":"HS Kim","year":"2016","unstructured":"Kim HS, Kim JH, Kim JW, et al. Chemotherapy in elderly patients with gastric cancer. J Cancer. 2016;7:88\u201394.","journal-title":"J Cancer."},{"key":"18357_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.35772\/ghm.2024.01080","volume":"7","author":"Y Yamada","year":"2025","unstructured":"Yamada Y, Seto Y, Yoshikawa T, et al. Postoperative adjuvant chemotherapy in patients with gastric cancer based on the Nationwide Gastric Cancer Registry in Japan. Glob Health Med. 2025;7:13\u201327.","journal-title":"Glob Health Med."},{"key":"18357_CR11","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s10147-017-1089-y","volume":"22","author":"T Aoyama","year":"2017","unstructured":"Aoyama T, Sato T, Maezawa Y, et al. Postoperative weight loss leads to poor survival through poor S-1 efficacy in patients with stage II\/III gastric cancer. Int J Clin Oncol. 2017;22:476\u201383.","journal-title":"Int J Clin Oncol."},{"key":"18357_CR12","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1245\/s10434-017-5923-2","volume":"24","author":"K Yamashita","year":"2017","unstructured":"Yamashita K, Kurokawa Y, Yamamoto K, et al. Risk factors for poor compliance with adjuvant S-1 chemotherapy for gastric cancer: a multicenter retrospective study. Ann Surg Oncol. 2017;24:2639\u201345.","journal-title":"Ann Surg Oncol."},{"key":"18357_CR13","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.ejso.2022.09.003","volume":"49","author":"S Nagasawa","year":"2023","unstructured":"Nagasawa S, Sato T, Morita J, et al. Solitary living worsens the continuation of adjuvant chemotherapy for gastric cancer. Eur J Surg Oncol. 2023;49:368\u201375.","journal-title":"Eur J Surg Oncol."},{"key":"18357_CR14","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s12672-025-02375-9","volume":"16","author":"F Ma","year":"2025","unstructured":"Ma F, Zheng Y, Cui J, et al. Survival benefits of postoperative adjuvant chemotherapy in adults aged \u2265 80 years with locally advanced gastric cancer: insights from a population-based study. Discov Oncol. 2025;16:653.","journal-title":"Discov Oncol."},{"key":"18357_CR15","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1634\/theoncologist.10-3-198","volume":"10","author":"MS Aapro","year":"2005","unstructured":"Aapro MS, K\u00f6hne CH, Cohen HJ, et al. Never too old? Age should not be a barrier to enrollment in cancer clinical trials. Oncologist. 2005;10:198\u201304.","journal-title":"Oncologist."},{"key":"18357_CR16","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12885-021-07919-0","volume":"21","author":"Y Liang","year":"2021","unstructured":"Liang Y, Zhao L, Chen H, et al. Survival analysis of elderly patients over 65 years old with stage II\/III gastric cancer treated with adjuvant chemotherapy after laparoscopic D2 gastrectomy: a retrospective cohort study. BMC Cancer. 2021;21:196.","journal-title":"BMC Cancer."},{"key":"18357_CR17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1159\/000515175","volume":"62","author":"C Kunisaki","year":"2021","unstructured":"Kunisaki C, Sato S, Tsuchiya N, et al. Real-world therapeutic outcomes of S-1 adjuvant chemotherapy for pStage II\/III gastric cancer in the elderly. Eur Surg Res. 2021;62:40\u201352.","journal-title":"Eur Surg Res."},{"key":"18357_CR18","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1186\/s12885-023-11244-z","volume":"23","author":"YH Shih","year":"2023","unstructured":"Shih YH, Lin HC, Liao PW, et al. The efficacy of adjuvant chemotherapy for older adults with stage II\/III gastric cancer: a retrospective cohort study. BMC Cancer. 2023;23:770.","journal-title":"BMC Cancer."},{"key":"18357_CR19","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00432-025-06230-w","volume":"151","author":"ZZ Shen","year":"2025","unstructured":"Shen ZZ, Li EZ, Zhang RL, et al. Adjuvant chemotherapy may have no significant survival benefit in older patients with stage II\/III gastric cancer: a multicenter retrospective study. J Cancer Res Clin Oncol. 2025;151:175.","journal-title":"J Cancer Res Clin Oncol."},{"key":"18357_CR20","doi-asserted-by":"publisher","first-page":"3768","DOI":"10.3390\/cancers15153768","volume":"15","author":"WL Chan","year":"2023","unstructured":"Chan WL, Liu X, Wong CK, et al. Adjuvant chemotherapy in older patients with gastric cancer: A population-based cohort study. Cancers (Basel). 2023;15:3768.","journal-title":"Cancers (Basel)."},{"key":"18357_CR21","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1007\/s10147-019-01468-0","volume":"24","author":"K Miyatani","year":"2019","unstructured":"Miyatani K, Saito H, Shimizu S, et al. Late start and insufficient S-1 dose in adjuvant chemotherapy can lead to poor prognosis in stage II\/III gastric cancer. Int J Clin Oncol. 2019;24:1190\u20136.","journal-title":"Int J Clin Oncol."},{"key":"18357_CR22","doi-asserted-by":"crossref","unstructured":"Miyatani K, Takahashi T, Shimizu S, et al. A higher preoperative cachexia index can result in the sufficient administration of S-1 adjuvant chemotherapy and lead to a good prognosis for elderly patients with stage II\/III gastric cancer. Surg Today. 2025.","DOI":"10.1007\/s00595-025-03038-6"},{"key":"18357_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.738550","volume":"8","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Qian L, Liu T, et al. Prevalence and prognostic value of malnutrition among elderly cancer patients using three scoring systems. Front Nutr. 2021;8:738550.","journal-title":"Front Nutr."},{"key":"18357_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11912-016-0535-8","volume":"18","author":"T Koll","year":"2016","unstructured":"Koll T, Pergolotti M, Holmes HM, et al. Supportive care in older adults with cancer: across the continuum. Curr Oncol Rep. 2016;18:51.","journal-title":"Curr Oncol Rep."},{"key":"18357_CR25","first-page":"2312","volume":"11","author":"K Nishibeppu","year":"2021","unstructured":"Nishibeppu K, Komatsu S, Kosuga T, et al. Cumulative total S-1 dose in adjuvant chemotherapy affects the long-term outcome following curative gastrectomy for gastric cancer. Am J Cancer Res. 2021;11:2312\u20138.","journal-title":"Am J Cancer Res."},{"key":"18357_CR26","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s12029-025-01239-3","volume":"56","author":"F Noji","year":"2025","unstructured":"Noji F, Yoshioka H, Jin R, Hatakeyama H, Sato H, Hisaka A. Adjuvant chemotherapy for gastric cancer may worsen prognosis in elderly women: retrospective analysis of individual patient data from the Classic study. J Gastrointest Cancer. 2025;56:142.","journal-title":"J Gastrointest Cancer."},{"key":"18357_CR27","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1093\/jjco\/hyy152","volume":"48","author":"T Mizutani","year":"2018","unstructured":"Mizutani T, Yamaguchi K, Mizusawa J, et al. A phase III trial to confirm modified S-1 adjuvant chemotherapy for pathological stage II\/III vulnerable elderly gastric cancer patients who underwent gastric resection (JCOG1507, Birdie). Jpn J Clin Oncol. 2018;48:1101\u20134.","journal-title":"Jpn J Clin Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18357-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18357-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18357-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T14:10:02Z","timestamp":1765289402000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18357-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,24]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["18357"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18357-8","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"type":"print","value":"1068-9265"},{"type":"electronic","value":"1534-4681"}],"subject":[],"published":{"date-parts":[[2025,9,24]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There are no conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}